StreetInsider.com News Articles

RBC Capital Reiterates Outperform Rating on HealthEquity, Inc (HQY) Following Mgmt Meet

Wed, 03 Jun 2026 05:06:18 -0400

RBC Capital analyst Daniel R. Perlin reiterated an Outperform rating and $108.00 price target on HealthEquity, Inc (NASDAQ: HQY)

The analyst comments "We are reiterating our Outperform rating and price target on HQY with increased confidence in the company's growth and margin opportunity. After hosting investor meetings with management, we came away with a sharper appreciation of its transformation into a digital platform with a flywheel that generates multiple avenues for monetization and operating leverage. While some revenue streams remain early innings, HQY believes it can return to DD growth. Investments in automation/ AI offer meaningful margin expansion opportunities, and with

Form 4 HEALTHEQUITY, INC. For: May 29 Filed by: Fiore Michael Henry

Tue, 02 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260602/26592940.html

Form 4 HEALTHEQUITY, INC. For: May 29 Filed by: Fiore Michael Henry

Tue, 02 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260602/26592940.html

Form 4 HEALTHEQUITY, INC. For: May 28 Filed by: Wellborn Gayle Furgurson

Mon, 01 Jun 2026 18:05:00 -0400

si-local-file:///var/storage/secattach/20260601/26585406.html

Form 4 HEALTHEQUITY, INC. For: May 28 Filed by: Wellborn Gayle Furgurson

Mon, 01 Jun 2026 18:05:00 -0400

si-local-file:///var/storage/secattach/20260601/26585406.html

Form 4 HEALTHEQUITY, INC. For: May 28 Filed by: Ladd Delano

Mon, 01 Jun 2026 18:02:00 -0400

si-local-file:///var/storage/secattach/20260601/26585394.html

Form 4 HEALTHEQUITY, INC. For: May 28 Filed by: Ladd Delano

Mon, 01 Jun 2026 18:02:00 -0400

si-local-file:///var/storage/secattach/20260601/26585394.html

HealthEquity, Inc (HQY) PT Raised to $111 at Citizens on Raised FY27-28 EPS Estimates

Mon, 01 Jun 2026 04:38:59 -0400

Citizens analyst Constantine Davides raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $111.00 (from $110.00) while maintaining a Market Outperform rating.

The analyst commented, "We are lifting our FY27 and FY28 non-GAAP EPS estimates to $4.70 (from $4.59) and $5.46 (from $5.32), respectively. Our FY27 EBITDA margin assumption improves by 50bps to 44.6%. We expect HQY's share gains to continue, based upon its innovative platform, breadth of channel partnerships, and its potential to extend its capabilities into new market opportunities. We reaffirm our Market Outperform rating. Our price target moves to $111 (24x our revised FY27 EPS estimate) from

HealthEquity, Inc (HQY) PT Raised to $111 at Citizens on Raised FY27-28 EPS Estimates

Mon, 01 Jun 2026 04:38:59 -0400

Citizens analyst Constantine Davides raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $111.00 (from $110.00) while maintaining a Market Outperform rating.

Form 144 HEALTHEQUITY, INC. Filed by: Fiore Michael Henry

Fri, 29 May 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260529/26575558.html

Form 144 HEALTHEQUITY, INC. Filed by: Fiore Michael Henry

Fri, 29 May 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260529/26575558.html

Form 144 HEALTHEQUITY, INC. Filed by: Wellborn Gayle Furgurson

Thu, 28 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260528/26568051.html

Form 144 HEALTHEQUITY, INC. Filed by: Wellborn Gayle Furgurson

Thu, 28 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260528/26568051.html

Form 144 HEALTHEQUITY, INC. Filed by: Ladd Delano

Thu, 28 May 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260528/26568044.html

Form 144 HEALTHEQUITY, INC. Filed by: Ladd Delano

Thu, 28 May 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260528/26568044.html

HealthEquity (HQY) Tops Q1 EPS by 13c; offers guidance

Thu, 28 May 2026 16:05:58 -0400

HealthEquity (NASDAQ: HQY) reported Q1 EPS of $1.24, $0.13 better than the analyst estimate of $1.11. Revenue for the quarter came in at $354.6 million versus the consensus estimate of $351.87 million.

GUIDANCE:

HealthEquity sees FY2027 EPS of $4.66-$4.73, versus the consensus of $4.63. HealthEquity sees FY2027 revenue of $1.41-1.42 million, versus the consensus of $1.412 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

HealthEquity (HQY) Tops Q1 EPS by 13c; offers guidance

Thu, 28 May 2026 16:05:58 -0400

GUIDANCE:

HealthEquity sees FY2027 EPS of $4.66-$4.73, versus the consensus of $4.63. HealthEquity sees FY2027 revenue of $1.41-1.42 million, versus the consensus of $1.412 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

Form 10-Q HEALTHEQUITY, INC. For: Apr 30

Thu, 28 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260528/26567150.html

Form 10-Q HEALTHEQUITY, INC. For: Apr 30

Thu, 28 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260528/26567150.html

Form 8-K HEALTHEQUITY, INC. For: May 28

Thu, 28 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260528/26567095.html

Form 8-K HEALTHEQUITY, INC. For: May 28

Thu, 28 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260528/26567095.html

HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

Thu, 28 May 2026 16:01:00 -0400

Increases Repurchase Program by $1.0 Billion

Highlights of the first quarter include:

Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.
Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.
Revenue increased 7% to $354.6 million.
Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.
Total HSA Assets grew 19% to $37.1 billion.
Returned $123.0 million to shareholders through stock repurchases.

DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) --

HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

Thu, 28 May 2026 16:01:00 -0400

Increases Repurchase Program by $1.0 Billion

Highlights of the first quarter include:

Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.
Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.
Revenue increased 7% to $354.6 million.
Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.
Total HSA Assets grew 19% to $37.1 billion.
Returned $123.0 million to shareholders through stock repurchases.

DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) --

HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

Thu, 28 May 2026 16:01:00 -0400

Increases Repurchase Program by $1.0 Billion

Highlights of the first quarter include:

Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.
Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.
Revenue increased 7% to $354.6 million.
Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.
Total HSA Assets grew 19% to $37.1 billion.
Returned $123.0 million to shareholders through stock repurchases.

DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) --

HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

Thu, 28 May 2026 16:01:00 -0400

Increases Repurchase Program by $1.0 Billion

Highlights of the first quarter include:

Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.
Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.
Revenue increased 7% to $354.6 million.
Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.
Total HSA Assets grew 19% to $37.1 billion.
Returned $123.0 million to shareholders through stock repurchases.

DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) --